SMTL ID : 2fzd.1

Human aldose reductase complexed with tolrestat at 1.08 A resolution.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.08 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: TOL.2 33 PLIP interactions: 33 interactions with chain A Hydrophobic interactions: A:W.21, A:Y.210, A:Y.210, A:Y.210 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:K.78, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:S.264, A:V.265, A:T.266, A:T.266, A:E.272, A:N.273 Water bridges: A:A.246, A:R.269, A:R.269, A:R.269, A:R.269 Salt bridges: A:K.22, A:K.263, A:R.269 pi-Cation interactions: A:R.269

1 x TOL: TOLRESTAT(Non-covalent)

TOL.2: 16 residues within 4Å: Chain A: W.21, V.48, Y.49, W.80, H.111, W.112, T.114, F.116, F.123, V.131, W.220, C.299, L.301, S.303, C.304 Ligands: NAP.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.80, A:W.112, A:F.123, A:L.301, A:L.301 Hydrogen bonds: A:Y.49 Salt bridges: A:K.78, A:H.111

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Steuber, H. et al., Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation Conditions. J.Mol.Biol. (2006)

Release Date

2006-10-03

Peptides

aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

aldose reductase

Related Entries With Identical Sequence